Dr Joo Ern Ang

Dr Joo Ern Ang is a distinguished Consultant Medical Oncologist, specialising in the oncological management of patients with gynaecological and neuroendocrine cancers. He holds the position of Clinical Lead for Gynaecological Oncology Research at Cambridge University Hospitals NHS Foundation Trust and is a recognised key opinion leader in his field.

Dr Ang is a global leader in novel cancer drug development. As Chief and Principal Investigator for over 30 national and international trials, he has led pioneering work from first-in-human studies to practice-changing Phase III research. His expertise is frequently sought in the development of antibody-drug conjugates, PARP inhibitors, immunotherapy, and precision biomarker discovery, with his research contributing to the NHS adoption of new standard treatments. His academic excellence, recognised by awards from the Wellcome Trust, NIHR, and ASCO, is grounded in multiple peer-reviewed publications.

Dr Ang is dedicated to making advanced, personalised care accessible. He offers both face-to-face and remote consultations. His approach integrates the latest research from his NHS and academic roles directly into his private practice, ensuring his patients benefit from the most innovative and effective therapeutic strategies available worldwide.